Assessing the impact of prostate cancer prevention and detection initiatives.

BACKGROUND

Prostate cancer is the most common male malignancy, yet prevention and early detection efforts show inconsistent uptake worldwide.

AIM: To identify which strategies and contextual factors enhance, or hinder, the effectiveness of prostate cancer prevention and screening.

METHODS

An integrative review yielded 19 peer-reviewed studies. Quality was appraised using Critical Appraisal Skills Programme; data were thematically synthesised.

RESULTS

Five themes surfaced. (1) Cultural attitudes-fear of digital rectal examination reduces participation, but tailored messaging can overcome this resistance. (2) Chemoprevention-finasteride and dutasteride cut incidence of prostrate cancer by ≈25 %, however, there are side effects which must be managed. (3) Biomarkers-the prostate-specific antigen test is the most widely used screening test, but the prostate cancer antigen 3 test is more accurate but increases costs. (4) Access models-mobile units, mass screening and theory-based education triple to six-fold prostate-specific antigen uptake in under-served groups, showing that low-barrier delivery can offset stigma. (5) Lifestyle-low-fat diets and micronutrients offer modest protection against prostate cancer, while obesity raises high-grade risk, highlighting synergy between behavioural and clinical interventions.

CONCLUSION

Integrating accurate diagnostics, culturally sensitive education, low-barrier outreach and lifestyle counselling offers the strongest pathway to equitable, sustainable prostate cancer control. Future studies should evaluate cost effectiveness and long-term adherence in diverse settings.